c-erbB-2 is not a major factor in the development of colorectal cancer.

作者: J A McKay , J F Loane , V G Ross , M-M Ameyaw , G I Murray

DOI: 10.1038/SJ.BJC.6600127

关键词:

摘要: We have investigated c-erbB-2 protein expression in a large cohort of well-characterized colorectal tumours, and subset lymph node metastases. also evaluated Val655Ile single nucleotide polymorphism, which is associated with an increased risk breast cancer, the cancer patients healthy control subjects. Immunohistochemical studies revealed that while 81.8% tumours expressed c-erbB-2, majority cases equivalent levels c-erb-B2 were seen adjacent normal mucosa. Colon significantly more likely to express than rectal (P=0.015). Only 52.4% metastases displayed staining patterns concordant their primary tumour, indicating determination cannot predict status PCR–RFLP analysis polymorphism demonstrated allele frequencies identical between group Caucasian subjects (Ile=0.80 Val=0.20 each case), it not related developing this population. Furthermore, there was no relationship gene (P=0.58). In terms prognosis, association either or presence Val patient survival (P>0.05 suggesting prognostic marker cancer.

参考文章(28)
Leah N. Klapper, Mark H. Kirschbaum, Michael Seta, Yosef Yarden, Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors Advances in Cancer Research. ,vol. 77, pp. 25- 79 ,(1999) , 10.1016/S0065-230X(08)60784-8
Joseph F. Loane, Stephanie Curran, Joy J. Douglas, Howard L. McLeod, Graeme I. Murray, Val G. Ross, Fareeda Y. Ahmed, Judith A. McKay, Expression of Cell Cycle Control Proteins in Primary Colorectal Tumors Does Not Always Predict Expression in Lymph Node Metastases Clinical Cancer Research. ,vol. 6, pp. 1113- 1118 ,(2000)
H.L. McLeod, J.A. McKay, E.S.R. Collie-Duguid, J. Cassidy, Therapeutic opportunities from tumour biology in metastatic colon cancer. European Journal of Cancer. ,vol. 36, pp. 1706- 1712 ,(2000) , 10.1016/S0959-8049(00)00150-7
Judith A. McKay, Joy J. Douglas, Val G. Ross, Stephanie Curran, Graeme I. Murray, Jim Cassidy, , Cyclin D1 protein expression and gene polymorphism in colorectal cancer International Journal of Cancer. ,vol. 88, pp. 77- 81 ,(2000) , 10.1002/1097-0215(20001001)88:1<77::AID-IJC12>3.0.CO;2-O
Yutaka Yonemura, Itasu Ninomiya, Kouichirou Tsugawa, Sachio Fushida, Takashi Fujimura, Itsuo Miyazaki, Tadao Uchibayashi, Yoshio Endou, Takuma Sasaki, Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach. Cancer Detection and Prevention. ,vol. 22, pp. 139- 146 ,(1998) , 10.1046/J.1525-1500.1998.CDOA02.X
XIAO-FENG Sun, JOHN M. Carstensen, OLLE StÅL, HONG Zhang, BO NordenskjÖLd, c-erbB-2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinoma. Apmis. ,vol. 103, pp. 309- 315 ,(1995) , 10.1111/J.1699-0463.1995.TB01112.X
Christophe R. Berney, Richard J. Fisher, Jia-lin Yang, Pamela J. Russell, Philip J. Crowe, Protein markers in colorectal cancer: predictors of liver metastasis. Annals of Surgery. ,vol. 230, pp. 179- 184 ,(1999) , 10.1097/00000658-199908000-00007
J. Papewalis, A.Yu. Nikitin, M.F. Rajewsky, G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene Nucleic Acids Research. ,vol. 19, pp. 5452- 5452 ,(1991) , 10.1093/NAR/19.19.5452-A
N L Chamberlain, R L Ward, N J Hawkins, Clinicopathological significance of erbB-2 expression in colorectal carcinoma. Oncology Reports. ,vol. 6, pp. 527- 558 ,(1999) , 10.3892/OR.6.3.527
Dino Amadori, Marco Maltoni, Annalisa Volpi, Oriana Nanni, Emanuela Scarpi, Beatrice Renault, Natalia S. Pellegata, Michele Gaudio, Enrico Magni, Guglielmina N. Ranzani, Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma Cancer. ,vol. 79, pp. 226- 232 ,(1997) , 10.1002/(SICI)1097-0142(19970115)79:2<226::AID-CNCR5>3.0.CO;2-I